The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort

The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort

(2014) Jaime Guzman et al.   ANNALS OF THE RHEUMATIC DISEASES

Description of Active Joint Count Trajectories in Juvenile Idiopathic Arthritis

(2014) R. A. Berard et al.   JOURNAL OF RHEUMATOLOGY

What Matters Most for Patients, Parents, and Clinicians in the Course of Juvenile Idiopathic Arthritis? A Qualitative Study

(2014) J. Guzman et al.   JOURNAL OF RHEUMATOLOGY

Defining Criteria for Disease Activity States in Nonsystemic Juvenile Idiopathic Arthritis Based on a Three-Variable Juvenile Arthritis Disease Activity Score

(2014) Alessandro Consolaro et al.   ARTHRITIS CARE & RESEARCH

The Biologic Basis of Clinical Heterogeneity in Juvenile Idiopathic Arthritis

(2014) Simon W. M. Eng et al.   Arthritis & Rheumatology

Delineating the Role of Multiple Intraarticular Corticosteroid Injections in the Management of Juvenile Idiopathic Arthritis in the Biologic Era

(2013) Charalampia Papadopoulou et al.   ARTHRITIS CARE & RESEARCH

Outcome and predicting factors of single and multiple intra-articular corticosteroid injections in children with juvenile idiopathic arthritis

(2011) S. Lanni et al.   RHEUMATOLOGY

American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis

(2011) Carol A. Wallace et al.   ARTHRITIS CARE & RESEARCH

2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features

(2011) Timothy Beukelman et al.   ARTHRITIS CARE & RESEARCH

Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis

(2010) Nicolino Ruperto et al.   ARTHRITIS AND RHEUMATISM

Antinuclear antibody-positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritis

(2010) Angelo Ravelli et al.   ARTHRITIS AND RHEUMATISM

Methotrexate Withdrawal at 6 vs 12 Months in Juvenile Idiopathic Arthritis in RemissionA Randomized Clinical Trial

(2010) Dirk Foell   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: Results of a Canadian multicenter, prospective inception cohort study

(2009) Kiem Oen et al.   ARTHRITIS AND RHEUMATISM

Developing a Standardized Definition for Disease "Flare" in Rheumatoid Arthritis (OMERACT 9 Special Interest Group)

(2009) C. O. BINGHAM et al.   JOURNAL OF RHEUMATOLOGY

Inactive disease in polyarticular juvenile idiopathic arthritis: current patterns and associations

(2009) S. Ringold et al.   RHEUMATOLOGY

Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial

(2008) Nicolino Ruperto et al.   LANCET

Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis

(2008) Daniel J. Lovell et al.   NEW ENGLAND JOURNAL OF MEDICINE